In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis
- PMID: 33608850
- PMCID: PMC7895740
- DOI: 10.1007/s43440-021-00233-3
In-hospital use of statins is associated with a reduced risk of mortality in coronavirus-2019 (COVID-19): systematic review and meta-analysis
Abstract
Background and aims: The idea of treating COVID-19 with statins is biologically plausible, although it is still controversial. The systematic review and meta-analysis aimed to address the association between the use of statins and risk of mortality in patients with COVID-19.
Methods: Several electronic databases, including PubMed, SCOPUS, EuropePMC, and the Cochrane Central Register of Controlled Trials, with relevant keywords up to 11 November 2020, were used to perform a systematic literature search. This study included research papers containing samples of adult COVID-19 patients who had data on statin use and recorded mortality as their outcome of interest. Risk estimates of mortality in statin users versus non-statin users were pooled across studies using inverse-variance weighted DerSimonian-Laird random-effect models.
Results: Thirteen studies with a total of 52,122 patients were included in the final qualitative and quantitative analysis. Eight studies reported in-hospital use of statins; meanwhile, the remaining studies reported pre-admission use of statins. In-hospital use of statin was associated with a reduced risk of mortality (RR 0.54, 95% CI 0.50-0.58, p < 0.00001; I2: 0%, p = 0.87), while pre-admission use of statin was not associated with mortality (RR 1.18, 95% CI 0.79-1.77, p = 0.415; I2: 68.6%, p = 0.013). The funnel plot for the association between the use of statins and mortality were asymmetrical.
Conclusion: This meta-analysis showed that in-hospital use of statins was associated with a reduced risk of mortality in patients with COVID-19.
Keywords: COVID-19; In-hospital; Mortality; Pre-admission; SARS-CoV-2; Statins.
Conflict of interest statement
The authors declare that there is no conflict of interest.
Figures
![Fig. 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7895740/bin/43440_2021_233_Fig1_HTML.gif)
![Fig. 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7895740/bin/43440_2021_233_Fig2_HTML.gif)
![Fig. 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7895740/bin/43440_2021_233_Fig3_HTML.gif)
![Fig. 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7895740/bin/43440_2021_233_Fig4_HTML.gif)
Similar articles
-
The protective association between statins use and adverse outcomes among COVID-19 patients: A systematic review and meta-analysis.PLoS One. 2021 Jun 24;16(6):e0253576. doi: 10.1371/journal.pone.0253576. eCollection 2021. PLoS One. 2021. PMID: 34166458 Free PMC article.
-
The use of statins was associated with reduced COVID-19 mortality: a systematic review and meta-analysis.Ann Med. 2021 Dec;53(1):874-884. doi: 10.1080/07853890.2021.1933165. Ann Med. 2021. PMID: 34096808 Free PMC article.
-
The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis.Am J Cardiovasc Drugs. 2022 Mar;22(2):167-181. doi: 10.1007/s40256-021-00490-w. Epub 2021 Aug 3. Am J Cardiovasc Drugs. 2022. PMID: 34341972 Free PMC article.
-
Improved COVID-19 Outcomes following Statin Therapy: An Updated Systematic Review and Meta-analysis.Biomed Res Int. 2021 Sep 23;2021:1901772. doi: 10.1155/2021/1901772. eCollection 2021. Biomed Res Int. 2021. PMID: 34568488 Free PMC article. Review.
-
Statins reduce mortality in patients with COVID-19: an updated meta-analysis of 147 824 patients.Int J Infect Dis. 2021 Sep;110:374-381. doi: 10.1016/j.ijid.2021.08.004. Epub 2021 Aug 8. Int J Infect Dis. 2021. PMID: 34375760 Free PMC article. Review.
Cited by
-
Association of antecedent statin use on 30-day, 60-day and 90-day mortality among Mississippi Medicaid beneficiaries diagnosed with COVID-19.BMJ Open. 2023 Nov 19;13(11):e076195. doi: 10.1136/bmjopen-2023-076195. BMJ Open. 2023. PMID: 37984946 Free PMC article.
-
Atherosclerosis, Cardiovascular Disease, and COVID-19: A Narrative Review.Biomedicines. 2023 Apr 18;11(4):1206. doi: 10.3390/biomedicines11041206. Biomedicines. 2023. PMID: 37189823 Free PMC article. Review.
-
Treating COVID-19: Targeting the Host Response, Not the Virus.Life (Basel). 2023 Mar 6;13(3):712. doi: 10.3390/life13030712. Life (Basel). 2023. PMID: 36983871 Free PMC article. Review.
-
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study.J Clin Med. 2022 Dec 17;11(24):7492. doi: 10.3390/jcm11247492. J Clin Med. 2022. PMID: 36556112 Free PMC article.
-
Survival impact of previous statin therapy in patients hospitalized with COVID-19.Med Clin (Engl Ed). 2023 Jan 5;160(1):1-9. doi: 10.1016/j.medcle.2022.03.021. Epub 2022 Dec 7. Med Clin (Engl Ed). 2023. PMID: 36504601 Free PMC article.
References
-
- Pranata R, Supriyadi R, Huang I, Permana H, Lim MA, Yonas E, et al. The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a meta-analysis. Clin Med Insights Circ Respir Pulm Med. 2020;14:1179548420959165. doi: 10.1177/1179548420959165. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous